BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 34185932)

  • 1. Shear-wave elastography to predict hepatocellular carcinoma after hepatitis C virus eradication: A systematic review and meta-analysis.
    Esposto G; Santini P; Galasso L; Mignini I; Ainora ME; Gasbarrini A; Zocco MA
    World J Gastroenterol; 2024 Mar; 30(10):1450-1460. PubMed ID: 38596502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-liver-related mortality in the DAA era: Insights from post-SVR patients with and without previous HCC history.
    Miuma S; Miyaaki H; Ichikawa T; Matsuzaki T; Goto T; Kamo Y; Shigeno M; Hino N; Ario K; Yanagi K; Tsutsumi T; Fukushima N; Nakashiki S; Yamasaki K; Hamasaki K; Shibata H; Arima K; Yamamichi S; Yamashima M; Takahashi K; Nakao Y; Fukushima M; Haraguchi M; Sasaki R; Ozawa E; Taura N; Nakao K
    J Med Virol; 2024 Mar; 96(3):e29432. PubMed ID: 38509793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular organellar abnormalities following elimination of hepatitis C virus.
    Aoyagi H; Iijima H; Gaber ES; Zaitsu T; Matsuda M; Wakae K; Watashi K; Suzuki R; Masaki T; Kahn J; Saito T; El-Kassas M; Shimada N; Kato K; Enomoto M; Hayashi K; Tsubota A; Mimata A; Sakamaki Y; Ichinose S; Muramatsu M; Wake K; Wakita T; Aizaki H
    Liver Int; 2023 Aug; 43(8):1677-1690. PubMed ID: 37312620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delays in fibrosis staging reduce the likelihood of achieving hepatitis C treatment and cure.
    Jones AT; Moreno-Walton L; Sossamon SD; Tahmeena F; Tran T; Briones C; Stevens R; Isaacson K; He H; Rhodes S; Percak J; Kissinger PJ
    Infect Dis (Lond); 2023 May; 55(5):309-315. PubMed ID: 36853886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.
    Rockey DC; Friedman SL
    Gastroenterology; 2021 Apr; 160(5):1502-1520.e1. PubMed ID: 33529675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of carotid atherosclerosis and peripheral artery disease after hepatitis C virus eradication by direct-acting antivirals.
    Cuciureanu T; Stanciu C; Năstasă RR; Stratina LE; Minea HO; Zenovia IS; Sfarti C; Muzica CM; Huiban L; Stafie RT; Singeap AM; Chiriac Ş; Cojocariu EC; Gîrleanu I; Petrea OC; Timofeiov S; Cuciureanu ID; Rotaru A; Trifan A
    Rom J Morphol Embryol; 2023; 64(4):483-491. PubMed ID: 38184828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients.
    Midori Y; Nosaka T; Hiramatsu K; Akazawa Y; Tanaka T; Takahashi K; Naito T; Matsuda H; Ohtani M; Nakamoto Y
    Front Cell Infect Microbiol; 2024; 14():1371429. PubMed ID: 38650735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained virologic response improved the long-term health-related quality of life in patients with chronic hepatitis C: a prospective national study in China.
    Huang R; Shang J; Chen H; Li J; Xie Q; Feng J; Wei L; Rao H
    BMC Infect Dis; 2024 Jan; 24(1):72. PubMed ID: 38200419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia.
    Butsashvili M; Gulbiani L; Kanchelashvili G; Kamkamidze T; Kajaia M; Gudavadze S; Kamkamidze G
    BMC Res Notes; 2024 Jun; 17(1):160. PubMed ID: 38858781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral elimination is essential for improving surgical outcomes of hepatitis C virus-related hepatocellular carcinoma: Multicenter retrospective analysis.
    Nakajima M; Kobayashi S; Wada H; Tomokuni A; Takahashi H; Noda T; Matsui H; Matsukuma S; Kanekiyo S; Shindo Y; Tokumitsu Y; Nakagami Y; Suzuki N; Takeda S; Tanabe M; Ito K; Hoshii Y; Eguchi H; Nagano H
    Ann Gastroenterol Surg; 2020 Nov; 4(6):710-720. PubMed ID: 33319162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision tree algorithm predicts hepatocellular carcinoma among chronic hepatitis C patients following viral eradication.
    Lu MY; Liu TW; Liang PC; Huang CI; Tsai YS; Tsai PC; Ko YM; Wang WH; Lin CC; Chen KY; Wang SC; Wei YJ; Hsu PY; Jang TY; Hsieh MY; Wang CW; Yeh ML; Lin ZY; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
    Am J Cancer Res; 2023; 13(1):190-203. PubMed ID: 36777503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995-2016.
    Bressler SS; Bruden D; Nolen LD; Bruce MG; Towshend-Bulson L; Spradling P; McMahon BJ
    Can J Gastroenterol Hepatol; 2022; 2022():2573545. PubMed ID: 35178364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
    Liver Int; 2016 Jun; 36(6):817-26. PubMed ID: 26787002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Nahon P; Bourcier V; Layese R; Audureau E; Cagnot C; Marcellin P; Guyader D; Fontaine H; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Leroy V; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Dharancy S; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Zucman D; Di Martino V; Thibaut V; Salmon D; Ziol M; Sutton A; Pol S; Roudot-Thoraval F;
    Gastroenterology; 2017 Jan; 152(1):142-156.e2. PubMed ID: 27641509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of serial FIB-4 score measurement for predicting the risk of hepatocarcinogenesis after hepatitis C virus eradication.
    Kumada T; Toyoda H; Yasuda S; Tada T; Tanaka J
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e513-e521. PubMed ID: 33852513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
    Ahumada A; Rayón L; Usón C; Bañares R; Alonso Lopez S
    World J Gastroenterol; 2021 Oct; 27(40):6737-6749. PubMed ID: 34790004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.
    Jacobson IM; Lim JK; Fried MW
    Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis.
    Kumada T; Toyoda H; Yasuda S; Tada T; Ito T; Tanaka J
    J Viral Hepat; 2021 Sep; 28(9):1293-1303. PubMed ID: 34185932
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.